Literature DB >> 3319418

Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.

C A Hitchcock1, N J Russell, K J Barrett-Bee.   

Abstract

Investigations of resistant mutants could help resolve differences and similarities in the action of azole and polyene antifungals whose modes of action are related; both disrupt membrane properties, such as permeability, by interfering with membrane sterols--polyenes by direct binding and azoles by inhibiting their synthesis. Studies of laboratory-derived mutants of Candida albicans which have an altered sterol content and/or an altered sterol composition do not provide evidence for a unified mechanism of polyene resistance. Clinical isolates of azole-resistant C. albicans have an increased or unaltered content of ergosterol and are impermeable to azoles. C. albicans 6.4, a laboratory-derived mutant resistant to both polyenes and azoles, is impermeable to azoles and has an increased content of methylated sterols. This unusual sterol composition resembles that of sensitive strains grown in the presence of azoles and may prevent polyene binding.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319418     DOI: 10.3109/10408418709104454

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  11 in total

Review 1.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.

Authors:  E K Manavathu; J R Dimmock; S C Vashishtha; P H Chandrasekar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 3.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

4.  Drug susceptibilities of yeast cells are affected by membrane lipid composition.

Authors:  Kasturi Mukhopadhyay; Avmeet Kohli; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Fluconazole resistance in Candida glabrata.

Authors:  C A Hitchcock; G W Pye; P F Troke; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

6.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

7.  Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

Authors:  D Sanglard; K Kuchler; F Ischer; J L Pagani; M Monod; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole.

Authors:  M A Ghannoum; B J Spellberg; A S Ibrahim; J A Ritchie; B Currie; E D Spitzer; J E Edwards; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

9.  Decreased accumulation or increased isoleucyl-tRNA synthetase activity confers resistance to the cyclic beta-amino acid BAY 10-8888 in Candida albicans and Candida tropicalis.

Authors:  K Ziegelbauer
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.

Authors:  H M Wardle; D Law; C B Moore; C Mason; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.